Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,981 to 2,000 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Rare myeloid sarcoma with KMT2A (MLL)-ELL fusion presenting as a vaginal wall mass. | Diagn Pathol | 2019 | 30922345 | PubTator, text mining | PubMed |
| Acute myeloid leukemia in an 86-year-old man with AML1/ETO treated with Homoharringtonine and Arsenic Trioxide: A case report. | Medicine (Baltimore) | 2019 | 30921216 | PubTator, text mining | PubMed |
| Diagnosis of fusion genes using targeted RNA sequencing. | Nat Commun | 2019 | 30918253 | PubTator, text mining | PubMed |
| MITF Expression Predicts Therapeutic Vulnerability to p300 Inhibition in Human Melanoma. | Cancer Res | 2019 | 30910803 | PubTator, text mining | PubMed |
| Acute Myeloid Leukemia with t(8;21)(q22;q22) and Trisomy 4: A Rare Occurrence in a Female Child. | Cureus | 2019 | 30899636 | PubTator, text mining | PubMed |
| Non-acute promyelocytic leukemia variant, acute myeloid leukemia with translocation (11;17). | Clin Case Rep | 2019 | 30899494 | PubTator, text mining | PubMed |
| Hoxa13 regulates expression of common Hox target genes involved in cartilage development to coordinate the expansion of the autopodal anlage. | Dev Growth Differ | 2019 | 30895612 | PubTator, text mining | PubMed |
| Impact of Additional Chromosomal Aberrations on the Disease Progression of Chronic Myelogenous Leukemia. | Front Oncol | 2019 | 30891424 | PubTator, text mining | PubMed |
| An Unusual Cause of Epistaxis: Paranasal Sinus Myeloid Sarcoma. | Case Rep Hematol | 2019 | 30891319 | PubTator, text mining | PubMed |
| Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML. | J Exp Med | 2019 | 30890554 | PubTator, text mining | PubMed |
| Clinico-Haematologic association and prognostic relevance of NPM1 and FLT3-ITD mutations in acute Myeloid Leukaemia. | Pak J Med Sci | 2019 | 30881390 | PubTator, text mining | PubMed |
| Epigenetic Modifications in Acute Myeloid Leukemia: Prognosis, Treatment, and Heterogeneity. | Front Genet | 2019 | 30881380 | PubTator, text mining | PubMed |
| Drosophila melanogaster: A Model Organism to Study Cancer. | Front Genet | 2019 | 30881374 | PubTator, text mining | PubMed |
| Mechanisms of drug resistance in acute myeloid leukemia. | Onco Targets Ther | 2019 | 30881045 | PubTator, text mining | PubMed |
| Increased methylation upstream of the MEG3 promotor is observed in acute myeloid leukemia patients with better overall survival. | Clin Epigenetics | 2019 | 30876483 | PubTator, text mining | PubMed |
| Revisiting Histone Deacetylases in Human Tumorigenesis: The Paradigm of Urothelial Bladder Cancer. | Int J Mol Sci | 2019 | 30875794 | PubTator, text mining | PubMed |
| Higher order genomic organization and epigenetic control maintain cellular identity and prevent breast cancer. | Genes Chromosomes Cancer | 2019 | 30873710 | PubTator, text mining | PubMed |
| Observation of clinical efficacy and toxic and side effects of pirarubicin combined with cytarabine on acute myeloid leukemia. | Oncol Lett | 2019 | 30867778 | PubTator, text mining | PubMed |
| Both Peripheral Blood and Urinary miR-195-5p, miR-192-3p, miR-328-5p and Their Target Genes PPM1A, RAB1A and BRSK1 May Be Potential Biomarkers for Membranous Nephropathy. | Med Sci Monit | 2019 | 30865617 | PubTator, text mining | PubMed |
| Identification of chromosomal abnormalities and genomic features in near-triploidy/tetraploidy-acute leukemia by fluorescence in situ hybridization. | Cancer Manag Res | 2019 | 30863166 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=100